Canada markets open in 6 hours 54 minutes

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2990-0.0087 (-2.83%)
At close: 04:00PM EDT
0.2990 0.00 (0.00%)
After hours: 07:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.30M
Enterprise Value 860.16k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.58
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.32

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3-76.64%
S&P500 52-Week Change 326.27%
52 Week High 32.7900
52 Week Low 30.2210
50-Day Moving Average 30.5949
200-Day Moving Average 31.0332

Share Statistics

Avg Vol (3 month) 3185.81k
Avg Vol (10 day) 3107.02k
Shares Outstanding 511.04M
Implied Shares Outstanding 611.17M
Float 810.68M
% Held by Insiders 13.15%
% Held by Institutions 11.15%
Shares Short (Apr 30, 2024) 43.96k
Short Ratio (Apr 30, 2024) 40.02
Short % of Float (Apr 30, 2024) 40.04%
Short % of Shares Outstanding (Apr 30, 2024) 40.04%
Shares Short (prior month Mar 28, 2024) 430.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Dec 09, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-82.05%
Return on Equity (ttm)-156.42%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.4M
Net Income Avi to Common (ttm)-10.06M
Diluted EPS (ttm)-1.5800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.83M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)543.2k
Total Debt/Equity (mrq)9.60%
Current Ratio (mrq)3.36
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-9.55M
Levered Free Cash Flow (ttm)-5.86M